bars13
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 16, 2018 (NCT04851977)
Timeline
Indications
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04681833 | Phase 2 | Feb 1, 2021 | CMAX Clinical Research, Government of China |
| NCT04851977 | Phase 1 | Oct 16, 2018 | Government of China, Monash University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 2 | 2018 |
| CMAX Clinical Research | For profit | 1 | 0 | 1 | 2021 |
| Monash University | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1